Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Tax harvesting to lower capital gains automates selling decisions to reduce taxes while maintaining portfolio goals.
25,625 articlesViking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Investors are valuing AI-enabled capacity in Bitcoin mining at a premium before construction is complete, marking a s...
CryptoQuant says MicroStrategy’s aggressive Bitcoin purchases risk cash strain in a volatile market, calling on Micro...
Carnival sailed to another quarter of record yields, yet its shares lag Royal Caribbean as debt, pricing power, and c...
Lucid is trading at a level that sparks debate: is this a true bargain or a value trap? This guide breaks down how to...
A June selloff tested leverage in Bitcoin-backed corporate debt, but the market has steadied. Dividend payments persi...
Philanthropy headlines are buzzing as Warren Buffett shifts a long-standing gift pattern. This piece breaks down what...
AT&T tells CNBC that Starlink faces a late-arrival risk, citing a fiber-first moat and evolving wireless growth. The ...
A drone leader sparked fresh optimism as AeroVironment stock took flight this week, jumping on news of real-world cou...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...
Two leading prediction-market platforms are pursuing high-value fundraising as U.S. lawmakers eye tighter rules. Iran...